Literature DB >> 10823262

Decreased sialic acid content of plasma von Willebrand factor in precapillary pulmonary hypertension.

A A Lopes1, B Ferraz de Souza, N Y Maeda.   

Abstract

In pulmonary hypertension, defective von Willebrand factor protein (vWF) lacking large multimers is present in circulation. This is associated with evidence of chronic endogenous platelet activation. Since asialo vWF has been shown to promote platelet activation and aggregation, we decided to investigate possible changes in the sialic acid content of plasma vWF in patients with precapillary pulmonary hypertension. vWF-associated sialic acid was measured indirectly as a wheat germ agglutinin-reactive substance (WGA-RS, Western blotting), and directly, as a thiobarbituric acid-reactive substance (TBA-RS, spectrophotometric reading). In the sixteen patients we studied (ages 8-45 yr), circulating vWF concentration was 2.18 times normal (p <0.001). However, patient vWF subunit contained 19% (WGA-RS) to 24% (TBA-RS) less sialic acid than the normal protein (p <0.05 for both determinations). In five patients, vWF-associated sialic acid was below 50% normal. We conclude that circulating vWF is hyposialylated in precapillary pulmonary hypertension and speculate that this might influence its interaction with platelets in vivo in these patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10823262

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  6 in total

Review 1.  Congenital heart disease and pulmonary arterial hypertension in South America (2013 Grover Conference series).

Authors:  Antonio Augusto Lopes; Patricia C Flores; Gabriel F Diaz; Sonia M F Mesquita
Journal:  Pulm Circ       Date:  2014-09       Impact factor: 3.017

2.  Desialylation of O-glycans activates von Willebrand factor by destabilizing its autoinhibitory module.

Authors:  Kayleigh M Voos; Wenpeng Cao; Nicholas A Arce; Emily R Legan; Yingchun Wang; Asif Shajahan; Parastoo Azadi; Pete Lollar; Xiaohui Frank Zhang; Renhao Li
Journal:  J Thromb Haemost       Date:  2021-09-26       Impact factor: 16.036

3.  Association of Single Nucleotide Polymorphisms in the ST3GAL4 Gene with VWF Antigen and Factor VIII Activity.

Authors:  Jaewoo Song; Cheng Xue; John S Preisser; Drake W Cramer; Katie L Houck; Guo Liu; Aaron R Folsom; David Couper; Fuli Yu; Jing-Fei Dong
Journal:  PLoS One       Date:  2016-09-01       Impact factor: 3.240

4.  Severe COVID-19 is associated with endothelial activation and abnormal glycosylation of von Willebrand factor in patients undergoing hemodialysis.

Authors:  Golzar Mobayen; Amrita Dhutia; Candice Clarke; Maria Prendecki; Stephen McAdoo; Renos Keniyopoullos; Talat Malik; Michael Laffan; Michelle Willicombe; Thomas McKinnon
Journal:  Res Pract Thromb Haemost       Date:  2021-09-12

Review 5.  The Glycobiology of Pulmonary Arterial Hypertension.

Authors:  Shia Vang; Phillip Cochran; Julio Sebastian Domingo; Stefanie Krick; Jarrod Wesley Barnes
Journal:  Metabolites       Date:  2022-04-01

6.  Sialylation on O-linked glycans protects von Willebrand factor from macrophage galactose lectin-mediated clearance.

Authors:  Soracha E Ward; Jamie M O'Sullivan; Alan B Moran; Daniel I R Spencer; Richard A Gardner; Jyotika Sharma; Judicael Fazavana; Marco Monopoli; Thomas A J McKinnon; Alain Chion; Sandra Haberichter; James S O'Donnell
Journal:  Haematologica       Date:  2022-03-01       Impact factor: 9.941

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.